Analysis of pan-cancer genomic datasets, including TCGA and GTEx, revealed that the DDX49 gene was aberrantly overexpressed across multiple human malignancies, with transcriptional levels significantly dysregulated in tumor tissues compared to their normal counterparts (P < 0.05). Here, DDX49 is linked to cancer.